531768 logo

Poly Medicure Limited Stock Price

BSE:531768 Community·₹193.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

531768 Share Price Performance

₹1,911.10
-401.85 (-17.37%)
32.8% undervalued intrinsic discount
₹2,841.99
Fair Value
₹1,911.10
-401.85 (-17.37%)
32.8% undervalued intrinsic discount
₹2,841.99
Fair Value
Price ₹1,911.10
AnalystHighTarget ₹2,841.99
AnalystConsensusTarget ₹2,277.33
AnalystLowTarget ₹2,016.00

531768 Community Narratives

AnalystHighTarget·Updated
Fair Value ₹2.84k 32.8% undervalued intrinsic discount

Aging Populations And Medtech Trends Will Unlock Global Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value ₹2.28k 16.1% undervalued intrinsic discount

Expanding Premium Medical Categories Will Unlock Global Opportunities

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystLowTarget·Updated
Fair Value ₹2.02k 5.2% undervalued intrinsic discount

Rising Regulation And Trade Tensions Will Curb Exports Despite Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent 531768 News & Updates

Poly Medicure Limited Key Details

₹16.9b

Revenue

₹5.5b

Cost of Revenue

₹11.3b

Gross Profit

₹7.8b

Other Expenses

₹3.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
35.28
Gross Margin
67.21%
Net Profit Margin
21.18%
Debt/Equity Ratio
6.5%

Poly Medicure Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
2 Rewards

About 531768

Founded
1995
Employees
3082
CEO
Himanshu Baid
WebsiteView website
www.polymedicure.com

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›